Recently, KDM3A, a demethylase that removes methyl form histone lysine H3K9, has been reported to promote urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α [34]. Here, KDM3A is linked to urinary bladder cancer.